loader

Longboard Pharmaceuticals Inc.

NASDAQ:LBPH
Featured Articles and Interviews

Top 5 Canadian Biotech Stocks of 2025

Press Releases

Longboard Pharmaceuticals Announces Positive Interim Results from the Open-Label Extension of the Phase 1b/2a PACIFIC Study Evaluating Bexicaserin in Participants with Developmental and Epileptic Encephalopathies

Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635

Longboard Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Updates

Longboard Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases. Its pipeline includes LP352, LP143, and LP659.

Interactive Chart

×